238 related articles for article (PubMed ID: 17704408)
41. Pilot study of conformal intensity modulated radiation therapy for localized prostate cancer.
Aillères N; Azria D; Thézenas S; Barbier N; Fenoglietto P; Delard R; Hay MH; Dubois JB
Cancer Radiother; 2004 Apr; 8(2):59-69. PubMed ID: 15063872
[TBL] [Abstract][Full Text] [Related]
42. Salvage intensity-modulated radiation therapy for locally recurrent prostate cancer after cryotherapy.
Choi M; Kim CR; Hung AY
Clin Genitourin Cancer; 2013 Jun; 11(2):85-8. PubMed ID: 23041454
[TBL] [Abstract][Full Text] [Related]
43. Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group.
Van Den Brink M; Van Den Hout WB; Stiggelbout AM; Klein Kranenbarg E; Marijnen CA; Van De Velde CJ; Kievit J;
J Clin Oncol; 2004 Jan; 22(2):244-53. PubMed ID: 14665610
[TBL] [Abstract][Full Text] [Related]
44. A method to separate the rectum from the prostate during proton beam radiotherapy of prostate cancer patients.
Isacsson U; Nilsson K; Asplund S; Morhed E; Montelius A; Turesson I
Acta Oncol; 2010 May; 49(4):500-5. PubMed ID: 20397777
[TBL] [Abstract][Full Text] [Related]
45. Two-year and lifetime cost-effectiveness of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for head-and-neck cancer.
Kohler RE; Sheets NC; Wheeler SB; Nutting C; Hall E; Chera BS
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):683-9. PubMed ID: 24138916
[TBL] [Abstract][Full Text] [Related]
46. Radiotherapy is a cost-effective palliative treatment for patients with bone metastasis from prostate cancer.
Konski A
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1373-8. PubMed ID: 15590167
[TBL] [Abstract][Full Text] [Related]
47. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.
Palm A; Johansson KA
Acta Oncol; 2007; 46(4):462-73. PubMed ID: 17497313
[TBL] [Abstract][Full Text] [Related]
48. Comparison of high-dose proton radiotherapy and brachytherapy in localized prostate cancer: a case-matched analysis.
Coen JJ; Zietman AL; Rossi CJ; Grocela JA; Efstathiou JA; Yan Y; Shipley WU
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e25-31. PubMed ID: 21470787
[TBL] [Abstract][Full Text] [Related]
49. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.
Jo Y; Hiratsuka J; Fujii T; Takenaka A; Fujisawa M
Urology; 2004 Sep; 64(3):556-60. PubMed ID: 15351592
[TBL] [Abstract][Full Text] [Related]
50. Proton-beam vs intensity-modulated radiation therapy. Which is best for treating prostate cancer?
Nguyen PL; Trofimov A; Zietman AL
Oncology (Williston Park); 2008 Jun; 22(7):748-54; discussion 754, 757. PubMed ID: 18619120
[TBL] [Abstract][Full Text] [Related]
51. Prolongation of total treatment time because of infrequently missed days of treatment is not associated with inferior biochemical outcome after dose-escalated radiation therapy for prostate cancer.
Liauw SL; Liauw SH
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):751-7. PubMed ID: 20932666
[TBL] [Abstract][Full Text] [Related]
52. How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons.
Peeters A; Grutters JP; Pijls-Johannesma M; Reimoser S; De Ruysscher D; Severens JL; Joore MA; Lambin P
Radiother Oncol; 2010 Apr; 95(1):45-53. PubMed ID: 20106540
[TBL] [Abstract][Full Text] [Related]
53. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
[TBL] [Abstract][Full Text] [Related]
54. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
Jones B
J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
[TBL] [Abstract][Full Text] [Related]
55. Cost-effectiveness analysis comparing intensity-modulated radiotherapy with conformational radiotherapy (3D-RT) for prostate cancer in the brazilian health system.
Viani GA; Arruda CV; Oliveira R
Rev Assoc Med Bras (1992); 2021 Jun; 67(5):724-730. PubMed ID: 34550263
[TBL] [Abstract][Full Text] [Related]
56. Prostate tumor alignment and continuous, real-time adaptive radiation therapy using electromagnetic fiducials: clinical and cost-utility analyses.
Quigley MM; Mate TP; Sylvester JE
Urol Oncol; 2009; 27(5):473-82. PubMed ID: 18625565
[TBL] [Abstract][Full Text] [Related]
57. Intensity-modulated radiation therapy (IMRT) versus 3-dimensional conformal radiation therapy (3D-CRT) for head and neck cancer: cost-effectiveness analysis.
Marta GN; Weltman E; Ferrigno R
Rev Assoc Med Bras (1992); 2018 Apr; 64(4):318-323. PubMed ID: 30133610
[TBL] [Abstract][Full Text] [Related]
58. Finding Value for Protons: The Case of Prostate Cancer?
Ojerholm E; Bekelman JE
Semin Radiat Oncol; 2018 Apr; 28(2):131-137. PubMed ID: 29735189
[TBL] [Abstract][Full Text] [Related]
59. Cost-effectiveness of adding an electron-beam boost to tangential radiation therapy in patients with negative margins after conservative surgery for early-stage breast cancer.
Hayman JA; Hillner BE; Harris JR; Pierce LJ; Weeks JC
J Clin Oncol; 2000 Jan; 18(2):287-95. PubMed ID: 10637242
[TBL] [Abstract][Full Text] [Related]
60. Proton therapy for prostate cancer.
Hoppe B; Henderson R; Mendenhall WM; Nichols RC; Li Z; Mendenhall NP
Oncology (Williston Park); 2011 Jun; 25(7):644-50, 652. PubMed ID: 21888265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]